Filing Details

Accession Number:
0001179022-18-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-02 08:25:50
Reporting Period:
2018-02-01
Accepted Time:
2018-02-02 08:25:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133416 Galectin Therapeutics Inc GALT Pharmaceutical Preparations (2834) 043562325
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1522478 D Kevin Freeman C/O Galectin Therapeutics, Inc.
4960 Peachtree Industrial Blvd., Ste 240
Norcross GA 30071
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-01 2,000 $4.10 16,000 No 4 P Indirect IRA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect IRA
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 22,043 Direct
Footnotes
  1. Includes 6,000 shares that the reporting person previously mistakenly reported as being held directly and which should have been reported as being held indirectly, by the reporting person's IRA.